Advanced nitric oxide generating nanomedicine for therapeutic applications

Z Wang, A Jin, Z Yang, W Huang - ACS nano, 2023 - ACS Publications
Nitric oxide (NO), a gaseous transmitter extensively present in the human body, regulates
vascular relaxation, immune response, inflammation, neurotransmission, and other crucial …

Coronary In-Stent Restenosis: JACC State-of-the-Art Review

G Giustino, A Colombo, A Camaj, K Yasumura… - Journal of the American …, 2022 - jacc.org
The introduction and subsequent iterations of drug-eluting stent technologies have
substantially improved the efficacy and safety of percutaneous coronary interventions …

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …

Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Trends and outcomes of restenosis after coronary stent implantation in the United States

ID Moussa, D Mohananey, J Saucedo… - Journal of the American …, 2020 - jacc.org
Background There is a paucity of data on the burden of in-stent restenosis (ISR) in the
United States as well as on its presentation and appropriate treatment strategies. Objectives …

Third universal definition of myocardial infarction

K Thygesen, JS Alpert, AS Jaffe, ML Simoons… - circulation, 2012 - Am Heart Assoc
Myocardial infarction (MI) can be recognised by clinical features, including
electrocardiographic (ECG) findings, elevated values of biochemical markers (biomarkers) …

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task …

GN Levine, ER Bates, JC Blankenship… - Journal of the American …, 2011 - jacc.org
Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. cardiosource. org), the American Heart Association …

[HTML][HTML] Management of in-stent restenosis

F Alfonso, JJ Coughlan, D Giacoppo, A Kastrati… - …, 2022 - ncbi.nlm.nih.gov
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …

Current treatment of in-stent restenosis

F Alfonso, RA Byrne, F Rivero, A Kastrati - Journal of the American College …, 2014 - jacc.org
Management of patients with in-stent restenosis (ISR) remains an important clinical problem.
Although drug-eluting stents (DES) have drastically reduced the incidence of ISR, treatment …

Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography

S Cassese, RA Byrne, T Tada, S Pinieck, M Joner… - Heart, 2014 - heart.bmj.com
Objective Systematic investigation of restenosis after percutaneous coronary intervention
(PCI) with bare metal stents (BMS) or first or second generation drug eluting stents (DES) in …

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting …

Y Zhu, K Liu, M Chen, Y Liu, A Gao, C Hu, H Li… - Cardiovascular …, 2021 - Springer
Abstract Background The triglyceride-glucose (TyG) index is an alternative marker of insulin
resistance (IR) and is closely associated with the prevalence and prognosis of …